December, 11 2014

Annual General Meeting of Association of Clinical Trials Organizations (ACTO) was held

The participants of the General Meeting approved 2014 Annual Report of ACTO and main activities for 2015.

The General Meeting admitted to membership two new companies – company AstraZeneca and research organization Dokumeds.

The election of the Board members took place. Leonid Dzivinsky (ClinStar), Maria Nassonova (Almedis), Peter Kosminsky (Janssen), Sergey Sudilovskiy (PPD), Anna Filimonova (Parexel), Marina Filippova (PSI) and Svetlana Zavidova (by virtue of her position) were elected for 2015.

Yuri Zuikov (inVentive Health Clinical) made a presentation on the results of a survey on assess the activities of ACTO.